Shaping Tomorrow: Singapore's Vision for Life Sciences, Pharmaceuticals and Biotech

Join us to discuss Singapore's vision for Life Sciences and Pharmbio and how organizations can align with the evolving investment policies

Following the announcement of the government’s $500M investment to refresh the public biosciences and medtech research infrastructure in the greater one-north area, Singapore is preparing for a new phase of development for these industries.

This event, co-organised by The French Chamber of Commerce and The Singaporean-German Chamber of Industry and Commerce, and Biotech Connection Singapore, will discuss the details behind this announcement and explore the opportunities it presents for companies and startups.

Industry experts will then discuss the next steps in Singapore’s journey—where future investments are headed, how emerging trends like biotech and AI-driven healthcare will shape the landscape, and what this means for businesses, researchers, and entrepreneurs.

Key Discussion Points

• Budget allocations and their impact on life sciences
• Success stories: How past investments have fueled growth
• Future investment priorities and emerging opportunities
• Challenges and policy considerations for sustaining momentum

Speakers

• Prof. Huck Hui Ng, Assistant Chief Executive, Research and Talent Development at A*STAR

• Zainab Sadat, General Manager and Head of Vaccines for SEA & India at Sanofi

• EDB (speaker to be announced)

Moderator

• Maximilian Englisch, Global Vice-President of Sales at WALDNER Group

Modalités d'accès